NCT01950286
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- Orebro University Hospital Örebro, Örebro County, Sweden
Clinical trial condition
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Explore clinical trials studying Precursor Cell Lymphoblastic Leukemia-Lymphoma. Study availability and eligibility vary by location and protocol.
120 public trials
51 recruiting studies
Precursor Cell Lymphoblastic Leukemia-Lymphoma trial results
NCT00019227
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
NCT00006009
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +19 more
- Locations
-
- Stanford University Medical Center Stanford, California, United States
NCT00089271
- Conditions
- Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Blood Protein Disorders, +97 more
- Locations
-
- University of Pittsburgh Pittsburgh, Pennsylvania, United States
NCT00005080
- Conditions
- Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Hematologic Diseases, +32 more
- Locations
-
- Cancer and Leukemia Group B Chicago, Illinois, United States
NCT00822432
- Conditions
- Burkitt Lymphoma, Central Nervous System Neoplasms, DNA Virus Infections, +24 more
- Locations
-
- Pitié-Salpêtrière Hospital Paris, France
- University Hospital Centre of Tours Tours, France
NCT00005580
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +37 more
- Locations
-
- New York Presbyterian Hospital - Cornell Campus New York, United States
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
- Massey Cancer Center Richmond, Virginia, United States
Active, Not Recruiting
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
NCT02981628
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +23 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States
Active, Not Recruiting
A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia
NCT03914625
- Conditions
- Abnormalities, Multiple, B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, +31 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- USA Health Strada Patient Care Center Mobile, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
Active, Not Recruiting
Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01)
NCT04703192
- Conditions
- Adult T Cell Leukemia/Lymphoma, Hematologic Diseases, Hemic and Lymphatic Diseases, +15 more
- Locations
-
- City Of Hope National Medical Center Duarte, California, United States
- Stanford University Medical Center - Cancer Clinical Trials Office - ONCOLOGY Palo Alto, California, United States
- University of California San Francisco San Francisco, California, United States
- University Of Colorado Cancer Center Aurora, Colorado, United States